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Abstract: Small-for-gestational-age (SGA) infants have been associated with increased risk of adverse
perinatal outcomes (APOs). In this work, we assess the predictive ability of the ultrasound-estimated
percentile weight (EPW) at 35 weeks of gestational age to predict late-onset SGA and APOs, according
to six growth standards, and whether the ultrasound–delivery interval influences the detection rate.
To this purpose, we analyze a retrospective cohort study of 9585 singleton pregnancies. EPWs at
35 weeks were calculated to the customized Miguel Servet University Hospital (MSUH) and Figueras
standards and the non-customized MSUH, Fetal Medicine Foundation (FMF), INTERGROWTH-21st,
and WHO standards. As results of our analysis, for a 10% false positive rate, the detection rates for
SGA ranged between 48.9% with the customized Figueras standard (AUC 0.82) and 60.8% with the
non-customized FMF standard (AUC 0.87). Detection rates to predict SGA by ultrasound–delivery
interval (1–6 weeks) show higher detection rates as intervals decrease. APOs detection rates ranged
from 27.0% with FMF to 7.9% with the Figueras standard. In conclusion, the ability of EPW to predict
SGA at 35 weeks is good for all standards, and slightly better for non-customized standards. The
APO detection rate is significantly greater for non-customized standards.
Keywords: adverse perinatal outcomes; birth weight; estimated fetal weight; estimated percentile
weight; fetal growth standard; small for gestational age; ultrasound
1. Introduction
Screenings for fetal growth abnormalities are essential components of antenatal care,
and fetal ultrasound plays a key role in the assessment of these conditions [1–3]. Small-
for-gestational-age (SGA) infants—those with a birth weight below the 10th percentile
J. Clin. Med. 2021, 10, 2984. https://doi.org/10.3390/jcm10132984 https://www.mdpi.com/journal/jcm
J. Clin. Med. 2021, 10, 2984 2 of 17
according to the standards [4]—have been associated with increased risk of adverse perina-
tal outcomes (APOs) [5].
These fetuses are the leading cause of stillbirth [6–8], and have more risks of both
neonatal morbidity [9] and mortality [10,11]. Recent studies have shown that an early
diagnosis of SGA in the third trimester can help to reduce APOs, reflecting the benefit of
prenatal diagnosis in these cases [12,13], although the time to perform the ultrasound is
not clearly established.
Several studies customized or not to maternal and fetal physiological variables have
been proposed to predict SGA [14]; these fetal growth standards [15–17] are based on
Hadlock et al.’s methodology [18,19], or on new multilevel models [20–22], and can be
customized to maternal and fetal physiological variables [23]. The estimation of the per-
centile adjusted for maternal and fetal characteristics is the property that postulates cus-
tomized standards as better detectors of adverse perinatal outcomes than population-based
standards (non-customized (NC)) [24]. The Royal College of Obstetricians and Gynecol-
ogists (RCOG) [25] recommends the use of customized birthweight curves to identify
SGA fetuses; the adjustment of fetal weight should be performed individually, and not
by population—although some studies have questioned the superiority of the EPW by
customized standards and its association with APOs [26,27], and SGA with APOs [28].
Furthermore, new standards have recently been published by EFW [29], includ-
ing international standards from the World Health Organization (WHO) [17] and the
INTERGROWTH-21st project [20,21], and local standards from the Fetal Medicine Founda-
tion (FMF) [22]. According to the recent review by McCowan et al. (2018), international
population ultrasound standards still require more comparative studies for validation [5].
Since the controversy arose about the most appropriate method to predict SGA, and
the lack of comparative assessment for the cited approaches, the objective of this study is to
compare the ability of EPW—according to six growth standards, by ultrasound at 35 weeks,
including population, population-customized, and international references—to predict
late-onset SGA, defined as a birth weight below the 10th percentile at term delivery. The
secondary objective is to determine whether the ultrasound–delivery interval influences
the detection rate of SGA newborns.
2. Materials and Methods
2.1. Study Design
This was a retrospective cohort study of births assisted at the Miguel Servet University
Hospital (MSUH), between March 2012 and December 2016. The inclusion criteria were as
follows: live singleton pregnancies controlled in MSUH from the first trimester of gestation;
fetal ultrasound assessment at gestational age of 35 (range 34–36) weeks; and deliver-
ies between 37 and 42 weeks of gestational age of fetuses without stillbirth associated
with malformations or chromosomal abnormalities. Of the 19,310 consecutive deliveries
assisted in our hospital in the period studied, the 9585 cases that fulfilled the specific inclu-
sion criteria—such as data availability to estimate percentile weights by standards—were
considered for the analysis. Study participants’ selection samples are detailed in Figure 1.
The last menstrual period was adjusted by first trimester ultrasound [30]. Universal
ultrasound screening was performed at 35 weeks (range 34–36 weeks) at the Ultrasound
and Prenatal Diagnosis Unit using either a Voluson 730 Expert, E6, E8 ultrasound machine
(General Electric, Healthcare, Zipf, Austria) or an Aloka Prosound SSD-5000 (Hitachi Aloka
Medical Systems, Tokyo, Japan). This ultrasound corresponds to the one that is routinely
performed in all pregnancies at our center to try to increase the detection of fetal growth
alterations [5].
EFW was calculated with the formula of each standard to which it was built. We used
Hadlock et al.’s [19] formula, which combines biparietal diameter, cephalic and abdominal
circumference, and femur length, for the MSHU, Figueras et al., and WHO standards;
and the version that uses cephalic and abdominal circumference and femur length for the
Fetal Medicine Foundation (FMF) standard. In addition, Stirnemann et al.’s formula [20],
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including only cephalic and abdominal circumference, was used to estimate percentile
weight for the INTERGROWTH-21st standard.




Figure 1. Flowchart of patient recruitment; EPW: estimated percentile weight. 
The last menstrual period was adjusted by first trimester ultrasound [30]. Universal 
ultrasound screening was performed at 35 weeks (range 34–36 weeks) at the Ultrasound 
and Prenatal Diagnosis Unit using either a Voluson 730 Expert, E6, E8 ultrasound machine 
(General Electric, Healthcare, Zipf, Austria) or an Aloka Prosound SSD-5000 (Hitachi 
Figure 1. Flowchart of patient recruitment; EPW: estimated percentile weight.
For the calculation of the EPW, we collected in the study the maternal age and body
mass index (BMI) at the beginning of pregnancy, parity, maternal and paternal height,
maternal ethnic origin, smoking habits, infant gender, birth weight, and ultrasound EFW.
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We also collected perinatal outcomes in order to analyze APOs in SGA infants at delivery,
defined as the occurrence of a 5-min Apgar score < 7, instrumental or cesarean delivery for
non-reassuring fetal status, arterial cord blood pH < 7.10, and stillbirth.
2.2. Estimated Percentile Weight
EPWs were calculated according to 6 different customized and NC growth standards,
including population, population-customized, and international references. For the cus-
tomized standards, the methodologies of Hadlock et al. [18] and Gardosi et al. [23] were
used for (1) the MSUH standard customized for parity, age, BMI, maternal height, paternal
height, and fetal gender, built using a modified version of Hadlock et al.’s growth charts
adjusted to our population, with a coefficient of variation that changes with gestational age
(Saviron-Cornudella et al. [16]); (2) and the Barcelona Clinic Hospital (Figueras et al. [15]).
For the NC standards, we used (3) an NC version of the MSUH standard (Saviron-
Cornudella et al. [16]); (4) the international population INTERGROWTH–21st [20,21]—a
multilevel mixed model whose main characteristic is that it includes pregnant women
without pathology; (5) the international WHO fetal growth standard [17], and (6) the FMF
local growth multilevel mixed model (Nicolaides at al [22]).
To assess ultrasound weight measures in the third trimester, EPWs were estimated
between 34 and 36 weeks of gestational age. The WHO EPW was calculated by interpolation
of the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles.
As a gold standard for the analysis, SGA was defined as a birth weight below the
10th percentile, using a growth reference for the Spanish population based on 9362 birth-
weights [31]. We did not focus our analysis on intrauterine growth-restricted fetuses
(IUGRs). As we did not perform Doppler ultrasound universally (only in cases of esti-
mated fetal weight < 10th percentile), we did not study the subgroup of SGA fetuses at
delivery with altered Doppler ultrasound. This is because a significant percentage of SGA
fetuses at delivery did not present an estimated fetal weight <10th percentile by ultrasound.
2.3. Statistical Analysis
Data were descriptively analyzed using medians and interquartile ranges for continu-
ous variables, and absolute and relative frequencies for categorical variables. The ability
of EPW provided by the six standards to predict SGA was analyzed using the area under
the receiver operating characteristic curve (AUC) [32]. Sensitivity (detection rate) was
established for false positive rates (FPR) of 5, 10, 15, and 20%. The percentile threshold
point corresponding to the FPR values was also calculated. AUCs were compared using
the DeLong test, and sensitivities through a proportion comparison test.
In addition, we built logistic regression models to estimate the OR and 95% confidence
interval that correspond to an increase of 1% in the EPW at 35 weeks, as a predictor for
SGA at delivery, performing a subanalysis for different ultrasound–delivery intervals
(1–6 weeks).
We analyzed the diagnostic ability of the EPW 10th percentile and SGA birthweights
to detect the following adverse perinatal outcomes: 5-min Apgar score < 7, instrumental
delivery for non-reassuring fetal status (NRFS), cesarean delivery for NRFS, arterial cord
blood pH < 7.10, and stillbirth. Comparison between APOs predicted by standards was
performed using a proportion test.
Analyses were performed using R version 3.6.2 language programming (The R Foun-
dation for Statistical Computing, Vienna, Austria) [33].
3. Results
3.1. Descriptive Results
Table 1 shows the descriptive characteristics of the pregnant women, and also displays
medians and percentiles 10 (P10) and 90 (P90) among groups for the six studied standards
for EFWs by ultrasound at 35 weeks (range from 34+0 to 36+6 weeks). WHO and FMF stan-
dards show an underestimation of the median expected value (50%) by ultrasound (median
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values 43.1%, P10–P90 range 7.5–74.9, and 37.6%, P10–P90 range 2.7–89.9, respectively),
while the Figueras standard shows an overestimation by ultrasound (median values 59.3%,
P10–P90 range 18.1–93.5).
Table 1. Parental baseline characteristics (top), pregnancy (middle), and perinatal characteristics
(bottom) of pregnancies. Data are reported as n (%) or medians (interquartile range); MSUH: Miguel
Servet University Hospital; NRFS: non-reassuring fetal status; WHO: World Health Organization.
Clinical Characteristics Pregnancies (n = 9585)
Parental characteristics
Maternal age (years) 33.3 (30.1–36.1)
Maternal body mass index (kg/m2) 23.2 (21.1–26.2)
Maternal height (cm) 163 (159–168)












Ultrasound parameters at 35 (34–36) weeks
Gestational age (weeks) at ultrasound 35.1 (35.0–35.3)
Estimated fetal weight (grams) by Hadlock 2495 (2314–2697)
Estimated fetal weight (grams) by Stirnemann 2421 (2209–2648)
Percentile by standard P50 (P10–P90)
Non-customized MSUH 52.6 (11.9–93.3)




Fetal Medicine Foundation 37.6 (2.7–89.9)
Pregnancy and perinatal outcomes




Birth weight 3310 (3030–3590)
Small for gestational age (<10th percentile) 902 (9.4%)
5-min Apgar score < 7 42 (0.4%)
Instrumental delivery for NRFS 161 (1.7%)
Cesarean delivery for NRFS 265 (2.8%)
Arterial cord blood pH < 7.10 254 (2.6%)
Stillbirth 19 (0.2%)
Any adverse perinatal outcome * 645 (6.7%)
* Excluding SGA.
EPW distributions are detailed in Figure 2, where a comparison of the percentage of
SGA is shown for each standard. The rate of SGA at birth in our cohort was 9.4% (n = 902).
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Blood pH < 7.10 Stillbirth Any APO
Total cohort 42 161 265 254 19 645
SGA 12 (28.6%) 2 (19.9%) 71 ( .8%) 45 (17.7%) 5 (26.3%) 139 (21.6%)
EPW < 10
Non-customized
MSUH 8 (19.0 ) 15 (9.3%) 43 (16.2%) 26 (10.2%) 5 (26.3%) 76 (11.8%)
Customized MSUH 6 (14.3 ) 9 (5.6%) 38 (14.3%) 22 (8.7%) 5 (26.3%) 62 (9.6%)
Figueras 5 (11.9%) 8 (5.0%) 32 (1 .1%) 18 (7.1%) 4 (21.1 51 (7.9%)
INTERGROWTH-
21st 7 (16.7%) 11 (6.8%) 39 (14.7%) 26 (10.2%) 5 (26.3%) 69 (10.7%)
WHO 12 (28.6%) 24 (14.9%) 57 (21.5%) 42 (16.5%) 7 (36.8%) 112 (17.4%)
FMF 17 (40.5%) 37 (23.0%) 89 (33.6%) 62 (24.4%) 10 (52.6%) 174 (27.0%)
3.2. Comparison of Standards
Table 3 displays values of AUCs and sensitivities plus the percentile threshold points
for different FPRs to predict SGA at delivery by ultrasound at 35 weeks (range
34+0–36+6 weeks). For a 10% FPR, the detection rates for SGA for all standards ranged
between 48.9% with the Figueras standard (AUC: 0.82; 95% CI: 0.80–0.83) to 60.8% with the
Fetal Medicine Foundation standard (AUC: 0.87; 95% CI: 0.85–0.88). These values were
obtained with percentile threshold points below 17.3%, 16.3%, 22.9%, 17.3%, 11.1% and
5.3% for NC MSUH, customized MSUH, Figueras, INTERGROWTH-21st, WHO, and FMF
standards, respectively. For a 20% FPR, the detection rates were between 66.4 and 78.92%,
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using 28.5%, 28.1%, 34.6%, 28.1%, 19.1%, and 13.1% as percentile threshold points for the
abovementioned standards, respectively.
Table 3. Area under the receiver operating characteristic curve and sensitivity analyses to detect small for gestational age
cases by ultrasound at 35 weeks (range 34–36 weeks) for different false positive rate (FPR) percentages; MSUH: Miguel Servet
University Hospital; Pc: percentile; WHO: World Health Organization. * Sensitive threshold percentile (Thr): percentile
point that corresponds to a false positive rate value.
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Figure 3 illustrates the receiver operating characteristic curve comparison and AUC for
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of the logistic regression model with the ORs and 95% CIs to predict SGA by ultrasound at
35 weeks, according to the standards.
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Figure 3. Receiver operating characteristic curves: comparison of fetal growth standards and area
under the curve (95% CIs) for prediction of small for gestational age newborns, using estimated
percentile weight by ultrasound at 35 weeks. Growth standards: non-customized Miguel Servet
University Hospital (MSUH), customized MSUH, Figueras et al., INTERGROWTH-21st, World
Health Organization (WHO), and F tal Medici e Foundation.
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p-values of the comparisons of the standard AUC values and sensitivity for a 90%
specificity are shown in Table 4. The Fetal Medicine Foundation and the non-customized
MSUH standards showed no statistically significant differences between them, with greater
SGA prediction ability than the Intergrowth-21st, Figueras, and WHO standards. Moreover,
in the comparison, the Intergrowth-21st and WHO standards showed significant differences
from the customized MSHU and Figueras standards. Finally, customized standards did
not show differences between them.




Figure 4. Odds ratios (ORs) and 95% confidence intervals (CIs) of standards in to predict small for 
gestational age according to estimated percentile weight by ultrasound at 35 weeks; MSUH: Miguel 
Servet University Hospital; WHO: World Health Organization. 
Regarding APO prediction by EPW < 10, in Table 2 we show that the Fetal Medicine 
Foundation and WHO standards reached the greatest detection rates—27.0% and 17.4% 
respectively—with statistically significant differences between them and the rest of stand-
ards. No statistically significant differences were detected in the any of the possible com-
parisons between the non-customized MSUH (11.8%), INTERGROWTH-21st (10.7%), cus-
tomized MSUH (9.6%), and Figueras (7.9%) standards, with the unique exception of the 
significant difference between the non-customized MSUH and Figueras standards. The 
instrumental deliveries for NRFS, cesarean deliveries for NRFS, and neonatal acidemia 
APOs might explain those differences. P-values of all comparisons are illustrated in Table 
4. 
3.3. Ultrasound-Delivery Interval: Comparison of Standards 
Table 5 displays values of AUCs and sensitivities for different FPRs to predict SGA 
by ultrasound–delivery interval (range 1–6 weeks). The observed results show higher de-
tection rates as the interval decreases. Figure 5 shows the prediction of small for gesta-
tional age cases, by standard, by ultrasound–delivery interval (1–6 weeks), for a 10% false 
positive rate. 
  
Figure 4. Odds ratios (ORs) and 95% confidence intervals (CIs) of standards in to predict small for
gestational age according to estimated percentile weight by ultrasound at 35 weeks; MSUH: Miguel
S vet University ospital; WHO: World Health Organization.
Table 4. Results of p-value tests to compare standards: area under the receiver operating characteristic curve (AUC)
and sensitivities (specificity 90%) to predict small for gestational age; and percentage of adverse perinatal outcome
(APO) diagnosis; NC: non-customized; C: customized; MSUH: Miguel Servet University Hospital; WHO: World Health
Organization.
Customized MSUH Figueras INTERGROWTH-21st WHO Fetal Medicine Foundation
AUC Sens APOs AUC Sens APOs AUC Sens APOs AUC Sens APOs AUC Sens APOs
NC MSUH <0.001 <0.001 0.242 <0.001 <0.001 0.025 <0.001 0.086 0.597 <0.001 0.071 0.006 0.169 0.900 <0.001
C MSUH 0.053 0.375 0.325 <0.001 0.030 0.580 <0.001 0.037 <0.001 <0.001 <0.001 <0.001
Figueras <0.001 0.002 0.103 <0.001 0.003 <0.001 <0.001 <0.001 <0.001
IG-21st 0.094 0.970 <0.001 <0.001 0.058 <0.001
WHO <0.001 0.048 <0.001
Regarding APO prediction by EPW < 10, in Table 2 we show that the Fetal Medicine
Foundation and WHO standards reached he greatest detection rates—27.0% and 17.4%
respectively—with statistically significant differences between them and the rest of stan-
dards. No statistically significant differences were detected in the any of the possible
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comparisons between the non-customized MSUH (11.8%), INTERGROWTH-21st (10.7%),
customized MSUH (9.6%), and Figueras (7.9%) standards, with the unique exception of the
significant difference between the non-customized MSUH and Figueras standards. The
instrumental deliveries for NRFS, cesarean deliveries for NRFS, and neonatal acidemia
APOs might explain those differences. p-values of all comparisons are illustrated in Table 4.
3.3. Ultrasound-Delivery Interval: Comparison of Standards
Table 5 displays values of AUCs and sensitivities for different FPRs to predict SGA
by ultrasound–delivery interval (range 1–6 weeks). The observed results show higher
detection rates as the interval decreases. Figure 5 shows the prediction of small for gesta-
tional age cases, by standard, by ultrasound–delivery interval (1–6 weeks), for a 10% false
positive rate.
Table 5. Area under the receiver operating characteristic curve and sensitivity analyses to predict small for gestational age
newborns using estimated percentile weight by ultrasound at 35 weeks (range 34–36 weeks), for different false positive rate
(FPR) percentages and ultrasound–delivery intervals (1–6 weeks); MSUH: Miguel Servet University Hospital; WHO: World
Health Organization.
Prediction of Small for
Gestational by Standard and
Ultrasound–Delivery Interval
N Area under theCurve (95% C.I.)
Sensitivity
FPR 5% FPR 10% FPR 15% FPR 20%
Non-customized MSUH
1 week (8–14 days) 156 0.94 (0.90–0.98) 58.3 (36.9–77.2) 75.0 (52.9–89.4) 92.0 (71.9–98.7) 96.0 (77.1–99.8)
2 weeks (15–21 days) 767 0.91 (0.88–0.94) 63.6 (53.3–72.9) 74.7 (64.8–82.7) 85.9 (77.1–91.8) 88.9 (80.6–94.1)
3 weeks (22–28 days) 1725 0.87 (0.84–0.90) 46.3 (39.1–53.7) 61.1 (53.7–68.0) 68.9 (61.7–75.3) 77.4 (70.7–83.0)
4 weeks (29–35 days) 2965 0.88 (0.86–0.90) 48.4 (42.5–54.3) 65.7 (59.9–71.1) 75.4 (69.9–80.2) 81.0 (75.9–85.3)
5 weeks (36–42 days) 2596 0.84 (0.81–0.87) 32.5 (26.1–39.6) 52.1 (44.8–59.3) 65.5 (58.3–72.1) 71.6 (64.6–77.7)
6 weeks (43–49 days) 1276 0.81 (0.77–0.85) 26.0 (17.8–36.1) 41.7 (31.9–52.2) 53.1 (42.7–63.3) 65.6 (55.1–74.8)
Customized MSUH
1 week (8–14 days) 156 0.92 (0.86–0.98) 58.3 (36.9–77.2) 79.2 (57.3–92.1) 83.3 (61.8–94.5) 91.7 (71.6–98.6)
2 weeks (15–21 days) 767 0.89 (0.85–0.92) 56.6 (46.3–66.4) 68.7 (58.5–77.4) 77.8 (68.1–85.3) 79.8 (70.3–86.9)
3 weeks (22–28 days) 1725 0.82 (0.79–0.85) 35.3 (28.6–42.6) 51.6 (44.3–58.9) 58.4 (51.0–65.4) 68.4 (61.2–74.8)
4 weeks (29–35 days) 2965 0.84 (0.82–0.86) 40.1 (34.4–46.0) 55.7 (49.8–61.5) 66.8 (61.0–72.1) 73.0 (67.4–78.0)
5 weeks (36–42 days) 2596 0.78 (0.74–0.81) 25.3 (19.5–32.1) 40.7 (33.8–48.0) 52.6 (45.3–59.8) 58.8 (51.5–65.7)
6 weeks (43–49 days) 1276 0.76 (0.71–0.80) 21.9 (14.4–31.7) 39.6 (29.9–50.1) 47.9 (37.7–58.3) 55.2 (44.7–65.2)
Figueras
1 week (8–14 days) 156 0.91 (0.85–0.96) 54.2 (33.3–73.9) 66.7 (44.7–83.6) 79.2 (57.3–92.1) 87.5 (66.5–96.7)
2 weeks (15–21 days) 767 0.89 (0.85–0.92) 56.6 (46.3–66.4) 65.7 (55.4–74.8) 79.8 (70.3–86.9) 83.8 (74.7–90.2)
3 weeks (22–28 days) 1725 0.82 (0.79–0.85) 37.4 (30.6–44.7) 48.9 (41.6–56.2) 61.6 (54.3–68.5) 65.8 (58.5–72.4)
4 weeks (29–35 days) 2965 0.83 (0.81–0.86) 37.0 (31.5–42.9) 51.2 (45.3–57.1) 63.0 (57.1–68.5) 72.3 (66.7–77.3)
5 weeks (36–42 days) 2596 0.77 (0.74–0.81) 26.8 (20.8–33.7) 42.3 (35.3–49.6) 50.5 (43.3–57.7) 57.7 (50.6–64.7)
6 weeks (43–49 days) 1276 0.74 (0.70–0.79) 20.8 (13.5–30.5) 35.4 (26.1–45.9) 42.7 (32.8–53.2) 51.0 (40.7–61.3)
INTERGROWTH–21st
1 week (8–14 days) 156 0.92 (0.87–0.96) 37.5 (19.6–59.2) 66.7 (44.7–83.6) 79.2 (57.3–92.1) 87.5 (66.5–96.7)
2 weeks (15–21 days) 767 0.89 (0.86–0.92) 54.5 (44.2–64.5) 70.7 (60.6–79.2) 76.8 (67.0–84.4) 81.8 (72.5–88.6)
3 weeks (22–28 days) 1725 0.84 (0.81–0.87) 38.4 (31.5–45.7) 55.8 (48.4–62.9) 63.7 (56.4–70.5) 72.6 (65.6–78.7)
4 weeks (29–35 days) 2965 0.87 (0.85–0–89) 41.5 (35.8–47.4) 62.6 (56.7–68.1) 73.3 (67.7–78.2) 79.9 (74.7–84.3)
5 weeks (36–42 days) 2596 0.82 (0.79–0.85) 32.5 (26.1–39.6) 49.0 (41.8–56.2) 61.3 (54.0–68.1) 68.0 (60.9–74.4)
6 weeks (43–49 days) 1276 0.79 (0.74–0.83) 17.7 (10.9–27.1) 34.4 (25.2–44.9) 51.0 (40.7–61.3) 56.2 (45.7–66.2)
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Table 5. Cont.
Prediction of Small for
Gestational by Standard and
Ultrasound–Delivery Interval
N Area under theCurve (95% C.I.)
Sensitivity
FPR 5% FPR 10% FPR 15% FPR 20%
WHO
1 week (8–14 days) 156 0.92 (0.87–0.97) 42.5 (23.5–63.8) 83.3 (61.8–94.5) 95.8 (76.8–99.8) 95.8 (76.8–99.8)
2 weeks (15–21 days) 767 0.89 (0.86–0.93) 59.6 (49.2–69.2) 71.7 (61.6–80.1) 71.7 (61.6–80.1) 78.8 (69.2–86.1)
3 weeks (22–28 days) 1725 0.86 (0.83–0.89) 44.7 (37.6–52.1) 60.5 (53.1–67.4) 66.3 (59.0–72.9) 74.2 (67.2–80.1)
4 weeks (29–35 days) 2965 0.85 (0.82–0.87) 35.6 (30.1–41.5) 57.1 (51.2–62.8) 63.3 (57.4–68.8) 74.4 (68.9–79.2)
5 weeks (36–42 days) 2596 0.82 (0.79–0.84) 30.4 (24.1–37.5) 47.9 (40.7–55.2) 52.6 (45.3–59.8) 61.3 (54.0–68.1)
6 weeks (43–49 days) 1276 0.77 (0.72–0.82) 28.1 (19.6–38.3) 39.6 (29.9–50.1) 44.8 (34.7–55.3) 57.3 (46.8–67.2)
Fetal Medicine Foundation
1 week (8–14 days) 156 0.94 (0.89–0.98) 58.3 (36.9–77.2) 75.0 (52.9–89.4) 91.7 (71.6–98.6) 95.8 (76.8–99.8)
2 weeks (15–21 days) 767 0.91 (0.88–0.94) 59.6 (49.2–69.2) 74.7 (64.8–82.7) 84.8 (75.9–91.0) 87.9 (79.4–93.3)
3 weeks (22–28 days) 1725 0.87 (0.84–0.90) 44.7 (37.6–52.1) 61.1 (53.7–68.0) 70.0 (62.9–76.3) 77.9 (71.2–83.4)
4 weeks (29–35 days) 2965 0.88 (0.86–0.90) 45.3 (39.5–51.2) 66.8 (61.0–72.1) 75.1 (69.6–79.9) 79.9 (74.7–84.3)
5 weeks (36–42 days) 2596 0.84 (0.81–0.86) 33.5 (27.0–40.7) 52.6 (45.3–59.8) 64.4 (57.2–71.0) 71.1 (64.1–77.3)
6 weeks (43–49 days) 1276 0.81 (0.77–0.85) 28.1 (19.6–38.3) 42.7 (32.8–53.2) 55.2 (44.7–65.2) 63.5 (53.0–72.9)J. Clin. Med. 2021, 10, x FOR PEER REVIEW 11 of 18  
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Figure 7. Receiver operating characteristic curves: comparison of fetal growth standards and area under the curve for pre-
diction of small for gestational age (SGA) by standard and by ultrasound–delivery interval (1–6 weeks). Growth standards:
non-customized Miguel Servet University Hospital (MSUH), customized MSUH, Figueras et al., INTERGROWTH-21st,
World Health Organization (WHO), and Fetal Medicine Foundation.
4. Discussion
4.1. Principal Findings
We have demonstrated the utility of EPW by ultrasound at 35 weeks (range 34+0–36+6
weeks) as a predictor of SGA fetuses at delivery at term. Adjusting the percentile threshold
points, the growth standards showed a similar good predictive ability, but with a significant
advantage for the non-customized MSUH and Fetal Medicine Foundation standards, and a
disadvantage for both the customized MSUH and Figueras standards, for SGA fetuses.
In our results, we found an underestimation of 10th percentile, by ultrasound at
35 weeks (range 34–36 weeks) with the WHO (7.5%) and FMF (2.7%) standards, and an
overestimation with the Figueras (18.1%) standard; for that, we can conclude that these
standards have a lack of calibration for our study population. The MSHU (NC (11.9%)
and customized (12.2%)) and INTERGROWTH-21st (12.7%) standards fit better to the 10th
percentile, with a minimum error, probably for the exclusion of premature deliveries.
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When we analyzed the APO-predictive ability of the six standards by percentile
weight <10 at 35th week of gestational age, the customized Fetal Medicine Foundation
and WHO standards showed the greatest diagnostic ability, with statistically significant
differences from the rest of standards. The main reason for this lies in the greater proportion
of 10th percentile EPW for the Fetal Medicine Foundation (21.2%) and WHO (12.6%) stan-
dards, In any case, with similar proportions of EPW < 10, the non-customized MSUH and
INTERGROWTH-21st standards show a better APO-predictive ability than the customized
MSUH and Figueras standards. A previous study did not find any significant differences
between the customized and non-customized standards when analyzing the predictive
ability of EPW to detect APOs; by contrast, using EPW > 90th percentile, we detected
significant differences [34].
4.2. Prediction by Fetal Biometry and Ultrasound–Delivery Interval
There is no international consensus on performing a universal ultrasound in the
third trimester; two international guidelines—the RCOG [35], and the American College
of Obstetrics and Gynecology (ACOG) [36]—do not recommend universal ultrasound
to detect fetal growth anomalies. Sovio el al [37], however, found that universal third
trimester ultrasound in nulliparous women, compared with selected ultrasound, tripled
the detection of SGA < P10 infants, and could identify FGR fetuses at increased risk of
neonatal morbidity.
The EPW at third trimester ultrasound over 32 weeks has been shown to be a good
predictive model (AUC > 0.85) for the detection of SGA at delivery in several studies,
although with detection rates limited for late-onset SGA births [4,38,39]. For gestational
time, the detection rate of SGA at delivery by ultrasound between 33–34 weeks is ap-
proximately 52%, and between 36–37 weeks it is approximately 60% (FPR of 10%) [40–42].
According to several studies, therefore, detection is higher the later the ultrasound is per-
formed [14,43,44]. In our case, the predictive capacity for SGA at delivery by ultrasound at
35 weeks is also limited for the six growth standards, and generally, a shorter ultrasound–
delivery interval is correlated with better prediction rates. In any case, the cutoff points
of the 10th percentiles by ultrasound at 35 weeks are moderate for the prediction of SGA
at delivery.
4.3. Prediction by Fetal Biometry and Ultrasound–Delivery Interval: Comparison of Standards
Blue et al., in 2018 [45], compared the RCOG and ACOG standards for the detection
of SGA at delivery, with a mean birth of 37.7 weeks and ultrasounds performed in the
previous 2 weeks, and showed that both standards had a moderate predictive capacity
(AUCs of 0.78 and 0.76, respectively). In another study by Blue in 2019 [46], the Hadlock
and INTERGROWTH-21st standards for the detection of SGA, with deliveries at 37 weeks
on average and ultrasound in the previous two weeks, showed good predictive capabilities
(>0.90), with cutoff points of the optimal percentile at 15% for the Hadlock standard and
22% for the INTERGROWTH-21st standard. Both studies are not comparable to ours;
although they show the minimum differences in SGA prediction regardless of the standard
used, neither of them studied customized standards.
In two studies by Odibo et al. in 2018 [47] and 2019 [48], using the same sample
obtained for the three different standards compared (INTERGROWTH-21st, a local cus-
tomized standard, and the Hadlock standard), a moderate predictive capacity for SGA
at delivery was achieved (0.67, 0.62, and 0.69, respectively), although with ultrasound
performed between 26 and 36+6 weeks, and an average ultrasound–delivery interval of
6.7 weeks—also different from our study.
Reboul et al., in 2017 [49], found that the Hadlock and the customized Gardosi stan-
dards had a moderate predictive capacity for SGA at delivery (0.768 and 0.708, respectively),
with the detection rates somewhat higher for the Hadlock standard, although with an
average of performing ultrasound at 32 weeks—lower than ours, which could justify the
lower predictive capacity.
J. Clin. Med. 2021, 10, 2984 14 of 17
4.4. Clinical and Research Implications
In clinical practice we can say that more important than the choice of the growth
standard is its calibration before clinical use, both by ultrasound and delivery, in the
reference population. The physiological and non-pathological characteristics of each
population are those that will allow us to calibrate the standard to be used.
There are several factors for which ultrasound in the third trimester presents limitations
when predicting SGA and FGRs at delivery, and some of them are unavoidable—especially
the systematic error of ultrasound at the time of EFW calculation [50]. With the current
studies carried out on the timing of performing the third trimester ultrasound and the
ultrasound–delivery interval, together with our comparative study of standards, we can
affirm that the timing that better predicts SGA cases is the one closest to delivery; however,
we cannot delay ultrasound universally to 37 weeks, since we would not detect early FGRs.
As we are not currently able to make that prediction, it will continue to be the subject of
future research.
According to our results, it would be appropriate to raise the ultrasound-estimated
weight percentile cutoff point above 10 for fetal growth control. This is because the 10th
percentile has been shown to be insufficient, and with low predictive capacity for SGA
at delivery and, therefore, fetuses that can potentially be IUGR even before delivery can
escape control and, thus, increase their morbidity and mortality. Our recommendation, in
the ultrasound during the third trimester, between 35 and 36 weeks, could be to raise the
cutoff point at least from the 10th to the 20th percentile for strict control of fetal growth.
4.5. Strengths and Limitations of the Study
Our study has several strengths, including the wide sample size close to 10,000 preg-
nancies. Ultrasound measurements were performed in routine clinical practice; thus,
weight estimations were more concentrated over specific weeks of gestational age. Lim-
itations of our investigation are that our data came from a single hospital, and their
retrospective nature could limit the generalization of our standards. Furthermore, the
information of the ultrasound was available to the obstetricians, which could mean a bias
in the management of the pregnancies. A small percentage of labors are inductions of labor
or cesarean sections programmed by IUGR, and they could act as confounding factors in
the study. Similarly, other cases of early termination due to other causes have not been
taken into account.
5. Conclusions
In summary, even with limited detection rates, the growth standards showed a sim-
ilar good predictive ability, with a statistically significant improvement by the use of
non-customized standards, for SGA at delivery by ultrasound at 35 weeks. Generally, a
shorter ultrasound delivery interval for the different standards was correlated with better
prediction rates for small gestational age cases. When focusing on the use of EPW < 10th
percentile at week 35 for the prediction of APOs, non-customized standards also demon-
strated an advantage over customized standards.
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